New scout dose method could make liver cancer treatment safer for lungs

NCT ID NCT07476651

First seen Apr 02, 2026 · Last updated May 12, 2026 · Updated 7 times

Summary

This study involves 30 adults with liver tumors who are scheduled for radioembolization, a treatment that delivers radiation directly to the tumor via tiny beads. Doctors currently use a test with a different particle (MAA) to see if the treatment might harm the lungs, but this test may not be perfectly accurate. The study tests a new approach using a small dose of the actual treatment beads (scout dose) to measure lung risk more precisely, aiming to improve safety and provide a backup when the standard test is unavailable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.